Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT
Ho, Vincent T., Kim, Haesook T., Bavli, Natalie, Mihm, Martin, Pozdnyakova, Olga, Piesche, Matthias, Daley, Heather, Reynolds, Carol, Souders, Nicholas C., Cutler, Corey, Koreth, John, Alyea, Edwin P.Volume:
1
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2017009084
Date:
November, 2017
File:
PDF, 1.91 MB
2017